Want to see JP:5187 full AI Analyst Report?
5187 Stock Chart & Stats
¥1037.00
-¥1.00(-0.11%)
At close: 4:00 PM EST
¥1037.00
-¥1.00(-0.11%)
Day’s Range― - ―
52-Week Range¥928.00 - ¥1,244.00
Previous CloseN/A
Volume5.50K
Average Volume (3M)7.98K
Market Cap
¥10.02B
Enterprise Value¥4.31B
Total Cash (Recent Filing)¥4.71B
Total Debt (Recent Filing)¥42.96M
Price to Earnings (P/E)14.1
Beta0.30
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.52%
Share Statistics
EPS (TTM)81.91
Shares Outstanding9,664,327
10 Day Avg. Volume3,800
30 Day Avg. Volume7,980
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.53
Price to Sales (P/S)0.64
P/FCF Ratio88.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageLow reported leverage (debt roughly 5% of equity) gives the company durable financial flexibility to fund R&D, manage working capital through procedure cycles, and support capex or dividends without relying on volatile external financing, lowering insolvency risk.
Steady Revenue Growth (2021–2025)Consistent low-to-mid single-digit top-line growth over multiple years indicates durable end-market demand and scalable commercial execution. Predictable revenue trends support capacity planning and provide a foundation for margin improvement if cost structure and operating leverage stabilize.
Recurring Consumables-based Business ModelA business model focused on single-use and regularly replaced consumables creates repeatable, contractable demand and a built-in installed base. That recurring revenue profile increases predictability, strengthens customer relationships, and supports long-term revenue visibility versus one-off device sales.
Bears Say
Volatile Profitability And Earnings QualityMarked swings in net income and uneven operating profit growth point to inconsistent cost control or non-recurring impacts. Persistent profitability volatility reduces the quality of reported earnings, complicates forecasting and capital allocation, and limits sustainable return generation.
Lumpy And Weakening Cash GenerationInconsistent cash conversion—strong one year but a sharp drop the next—raises execution risk around working capital and investment timing. Weak or lumpy free cash flow can constrain dividends, R&D, or capex, and may force external funding if adverse trends persist.
Exposure To Procedure Volumes And Reimbursement CyclesRevenue sensitivity to hospital procedure volumes, procurement timing, and reimbursement policy creates structural exposure to policy shifts and secular declines in procedure mix. Limited pricing power in institutional procurement can compress margins and make revenues cyclical during policy or volume headwinds.
Create Medic Co., Ltd. News
5187 FAQ
What was Create Medic Co., Ltd.’s price range in the past 12 months?
Create Medic Co., Ltd. lowest stock price was ¥928.00 and its highest was ¥1244.00 in the past 12 months.
What is Create Medic Co., Ltd.’s market cap?
Create Medic Co., Ltd.’s market cap is ¥10.02B.
When is Create Medic Co., Ltd.’s upcoming earnings report date?
Create Medic Co., Ltd.’s upcoming earnings report date is Jul 30, 2026 which is in 27 days.
How were Create Medic Co., Ltd.’s earnings last quarter?
Create Medic Co., Ltd. released its earnings results on May 07, 2026. The company reported ¥18.4 earnings per share for the quarter, beating the consensus estimate of N/A by ¥18.4.
Is Create Medic Co., Ltd. overvalued?
According to Wall Street analysts Create Medic Co., Ltd.’s price is currently Overvalued.
Does Create Medic Co., Ltd. pay dividends?
Create Medic Co., Ltd. pays a Semiannually dividend of ¥27 which represents an annual dividend yield of 3.52%. See more information on Create Medic Co., Ltd. dividends here
What is Create Medic Co., Ltd.’s EPS estimate?
Create Medic Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Create Medic Co., Ltd. have?
Create Medic Co., Ltd. has 9,664,327 shares outstanding.
What happened to Create Medic Co., Ltd.’s price movement after its last earnings report?
Create Medic Co., Ltd. reported an EPS of ¥18.4 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.586%.
Which hedge fund is a major shareholder of Create Medic Co., Ltd.?
Currently, no hedge funds are holding shares in JP:5187
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Create Medic Co., Ltd.
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman, suprapubic, and nephrostomy balloon catheters, as well as self-catheterization set, all silicone self-catheter for replacement, pure-cath, nephrostomy kit, cystostomy set, and all silicone malecot catheter; and gastroenterology products, such as all silicone ileus, stomach, and sengstaken blakemore tubes, as well as transanal ileus decompression tube set. It also provides PEG products comprising PEG kit pull-method, with loop fixture, and bumper type, as well as CLINY introducer PEG kit, loop fixture II, all silicone gastrostomy balloon catheter for replacement, balloon button set, facil button for replacement, gastrostomy replacement catheter set, all silicone PEG J catheter, and transgastric jejunal balloon tube and guidewire set; surgery products, which include PTC drainage tube, PTCD kit, cholangio-entero tube, and internal external drainage catheter for PTCD; all silicone endotracheal and tracheostomy tubes and micro catheter; and OEM products. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---





